Selected research
Market Structure
Global China PD-L1 and PIK3CA Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global China PD-L1 and PIK3CA Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for China PD-L1 and PIK3CA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for China PD-L1 and PIK3CA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for China PD-L1 and PIK3CA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for China PD-L1 and PIK3CA Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of China PD-L1 and PIK3CA Testing include Agilent Technologies, EntroGen, QIAGEN, Amoy Diagnostics, Roche and ACCB Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global China PD-L1 and PIK3CA Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of China PD-L1 and PIK3CA Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents China PD-L1 and PIK3CA Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the China PD-L1 and PIK3CA Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
China PD-L1 and PIK3CA Testing Segment by Company
Agilent Technologies
EntroGen
QIAGEN
Amoy Diagnostics
Roche
ACCB Biotech
China PD-L1 and PIK3CA Testing Segment by Type
PD-L1 Testing
PIK3CA Testing
China PD-L1 and PIK3CA Testing Segment by Application
Hospital
Diagnostic Center
Others
China PD-L1 and PIK3CA Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global China PD-L1 and PIK3CA Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of China PD-L1 and PIK3CA Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of China PD-L1 and PIK3CA Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of China PD-L1 and PIK3CA Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global China PD-L1 and PIK3CA Testing industry.
Chapter 3: Detailed analysis of China PD-L1 and PIK3CA Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, China PD-L1 and PIK3CA Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- PD-L1 Testing
- PIK3CA Testing
Applications
- Hospital
- Diagnostic Center
- Others
Companies covered
- Agilent Technologies
- EntroGen
- QIAGEN
- Amoy Diagnostics
- Roche
- ACCB Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 PD-L1 Testing
- 1.2.3 PIK3CA Testing
- 1.3 Market Analysis by Application
- 1.3.1 Global China PD-L1 and PIK3CA Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Diagnostic Center
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global China PD-L1 and PIK3CA Testing Growth Trends by Region
- 1.5.1 Global China PD-L1 and PIK3CA Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 China PD-L1 and PIK3CA Testing Market Size by Region (2021-2026)
- 1.5.3 China PD-L1 and PIK3CA Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global China PD-L1 and PIK3CA Testing Market Dynamics
- 2.1 China PD-L1 and PIK3CA Testing Industry Trends
- 2.2 China PD-L1 and PIK3CA Testing Industry Drivers
- 2.3 China PD-L1 and PIK3CA Testing Industry Opportunities and Challenges
- 2.4 China PD-L1 and PIK3CA Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global China PD-L1 and PIK3CA Testing Revenue by Company (2021-2026)
- 3.2 Global China PD-L1 and PIK3CA Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global China PD-L1 and PIK3CA Testing Key Company Head office and Area Served
- 3.4 Global China PD-L1 and PIK3CA Testing Company, Product Type & Application
- 3.5 Global China PD-L1 and PIK3CA Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global China PD-L1 and PIK3CA Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 China PD-L1 and PIK3CA Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 China PD-L1 and PIK3CA Testing Tier 1, Tier 2, and Tier 3
4 China PD-L1 and PIK3CA Testing Market by Type
- 4.1 Global China PD-L1 and PIK3CA Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global China PD-L1 and PIK3CA Testing Market Size by Type (2021-2032)
- 4.3 Global China PD-L1 and PIK3CA Testing Market Size Share by Type (2021-2032)
5 China PD-L1 and PIK3CA Testing Market by Application
- 5.1 Global China PD-L1 and PIK3CA Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global China PD-L1 and PIK3CA Testing Market Size by Application (2021-2032)
- 5.3 Global China PD-L1 and PIK3CA Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Agilent Technologies
- 6.1.1 Agilent Technologies Company Information
- 6.1.2 Agilent Technologies Business Overview
- 6.1.3 Agilent Technologies China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Agilent Technologies China PD-L1 and PIK3CA Testing Product Portfolio
- 6.1.5 Agilent Technologies Recent Developments
- 6.2 EntroGen
- 6.2.1 EntroGen Company Information
- 6.2.2 EntroGen Business Overview
- 6.2.3 EntroGen China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 EntroGen China PD-L1 and PIK3CA Testing Product Portfolio
- 6.2.5 EntroGen Recent Developments
- 6.3 QIAGEN
- 6.3.1 QIAGEN Company Information
- 6.3.2 QIAGEN Business Overview
- 6.3.3 QIAGEN China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 QIAGEN China PD-L1 and PIK3CA Testing Product Portfolio
- 6.3.5 QIAGEN Recent Developments
- 6.4 Amoy Diagnostics
- 6.4.1 Amoy Diagnostics Company Information
- 6.4.2 Amoy Diagnostics Business Overview
- 6.4.3 Amoy Diagnostics China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Amoy Diagnostics China PD-L1 and PIK3CA Testing Product Portfolio
- 6.4.5 Amoy Diagnostics Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Roche China PD-L1 and PIK3CA Testing Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 ACCB Biotech
- 6.6.1 ACCB Biotech Company Information
- 6.6.2 ACCB Biotech Business Overview
- 6.6.3 ACCB Biotech China PD-L1 and PIK3CA Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 ACCB Biotech China PD-L1 and PIK3CA Testing Product Portfolio
- 6.6.5 ACCB Biotech Recent Developments
7 North America
- 7.1 North America China PD-L1 and PIK3CA Testing Market Size (2021-2032)
- 7.2 North America China PD-L1 and PIK3CA Testing Market Size by Type
- 7.2.1 North America China PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 7.2.2 North America China PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 7.2.3 North America China PD-L1 and PIK3CA Testing Market Share by Type (2021-2032)
- 7.3 North America China PD-L1 and PIK3CA Testing Market Size by Application
- 7.3.1 North America China PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 7.3.2 North America China PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 7.3.3 North America China PD-L1 and PIK3CA Testing Market Share by Application (2021-2032)
- 7.4 North America China PD-L1 and PIK3CA Testing Market Size by Country
- 7.4.1 North America China PD-L1 and PIK3CA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America China PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
- 7.4.3 North America China PD-L1 and PIK3CA Testing Market Size by Country (2027-2032)
- 7.4.4 North America China PD-L1 and PIK3CA Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe China PD-L1 and PIK3CA Testing Market Size (2021-2032)
- 8.2 Europe China PD-L1 and PIK3CA Testing Market Size by Type
- 8.2.1 Europe China PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 8.2.2 Europe China PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 8.2.3 Europe China PD-L1 and PIK3CA Testing Market Share by Type (2021-2032)
- 8.3 Europe China PD-L1 and PIK3CA Testing Market Size by Application
- 8.3.1 Europe China PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 8.3.2 Europe China PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 8.3.3 Europe China PD-L1 and PIK3CA Testing Market Share by Application (2021-2032)
- 8.4 Europe China PD-L1 and PIK3CA Testing Market Size by Country
- 8.4.1 Europe China PD-L1 and PIK3CA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe China PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
- 8.4.3 Europe China PD-L1 and PIK3CA Testing Market Size by Country (2027-2032)
- 8.4.4 Europe China PD-L1 and PIK3CA Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China China PD-L1 and PIK3CA Testing Market Size (2021-2032)
- 9.2 China China PD-L1 and PIK3CA Testing Market Size by Type
- 9.2.1 China China PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 9.2.2 China China PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 9.2.3 China China PD-L1 and PIK3CA Testing Market Share by Type (2021-2032)
- 9.3 China China PD-L1 and PIK3CA Testing Market Size by Application
- 9.3.1 China China PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 9.3.2 China China PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 9.3.3 China China PD-L1 and PIK3CA Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia China PD-L1 and PIK3CA Testing Market Size (2021-2032)
- 10.2 Asia China PD-L1 and PIK3CA Testing Market Size by Type
- 10.2.1 Asia China PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 10.2.2 Asia China PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 10.2.3 Asia China PD-L1 and PIK3CA Testing Market Share by Type (2021-2032)
- 10.3 Asia China PD-L1 and PIK3CA Testing Market Size by Application
- 10.3.1 Asia China PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 10.3.2 Asia China PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 10.3.3 Asia China PD-L1 and PIK3CA Testing Market Share by Application (2021-2032)
- 10.4 Asia China PD-L1 and PIK3CA Testing Market Size by Country
- 10.4.1 Asia China PD-L1 and PIK3CA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia China PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
- 10.4.3 Asia China PD-L1 and PIK3CA Testing Market Size by Country (2027-2032)
- 10.4.4 Asia China PD-L1 and PIK3CA Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa China PD-L1 and PIK3CA Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst